Race Oncology Limited (RAONF)

USD 1.22

(0.0%)

Gross Profit Summary of Race Oncology Limited

  • Race Oncology Limited's latest annual gross profit in 2024 was 1.38 Million AUD , down -51.29% from previous year.
  • Race Oncology Limited's latest quarterly gross profit in 2024 Q4 was -93.72 Thousand USD , down 0.0% from previous quarter.
  • Race Oncology Limited reported a annual gross profit of 2.85 Million AUD in annual gross profit 2023, up 544.95% from previous year.
  • Race Oncology Limited reported a annual gross profit of 294.65 Thousand AUD in annual gross profit 2022, up 271.23% from previous year.
  • Race Oncology Limited reported a quarterly gross profit of -95.71 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • Race Oncology Limited reported a quarterly gross profit of -93.63 Thousand USD for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Race Oncology Limited (2024 - 2013)

Historical Annual Gross Profit of Race Oncology Limited (2024 - 2013)

Year Gross Profit Gross Profit Growth
2024 1.38 Million AUD -51.29%
2023 2.85 Million AUD 544.95%
2022 294.65 Thousand AUD 271.23%
2021 79.37 Thousand AUD 194.92%
2020 -83.61 Thousand AUD -126.54%
2019 -36.91 Thousand AUD 37.79%
2018 -59.33 Thousand AUD 69.06%
2017 -191.76 Thousand AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%
2013 - AUD 0.0%

Peer Gross Profit Comparison of Race Oncology Limited

Name Gross Profit Gross Profit Difference
Eiger BioPharmaceuticals, Inc. 14.99 Million USD 90.733%
Nanobac Pharmaceuticals, Incorporated 3102.00 USD -44707.06%
SQZ Biotechnologies Company 9.79 Million USD 85.809%
Evofem Biosciences, Inc. 11.7 Million USD 88.126%
Santhera Pharmaceuticals Holding AG 119.1 Million USD 98.833%
Mesoblast Limited -35.16 Million USD 103.952%
Propanc Biopharma, Inc. -34.15 Thousand USD 4170.029%
Genus plc 178.7 Million USD 99.222%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -238.867%
Marizyme, Inc. 457.7 Thousand USD -203.672%
ContraFect Corporation -154 Thousand USD 1002.542%
Nymox Pharmaceutical Corporation -11 Thousand USD 12735.591%
PsyBio Therapeutics Corp. -50 Thousand USD 2879.83%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -1710.705%
Intellipharmaceutics International Inc. 65.72 Thousand USD -2014.647%
AXIM Biotechnologies, Inc. -387.5 Thousand USD 458.687%
MultiCell Technologies, Inc. 49.32 USD -2818056.934%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 40.26 Million USD 96.548%
EV Biologics, Inc. 48.9 Thousand USD -2742.362%
Q BioMed Inc. -8988.00 USD 15564.119%
Emmaus Life Sciences, Inc. 28.25 Million USD 95.081%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. -15.42 Thousand USD 9111.378%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 220.1 Million USD 99.369%
Oncotelic Therapeutics, Inc. 70 Thousand USD -1885.593%
Skye Bioscience, Inc. -124.25 Thousand USD 1218.635%
Therapeutic Solutions International, Inc. 62.22 Thousand USD -2133.656%
THC Farmaceuticals, Inc. -4952.00 USD 28167.75%
Arch Therapeutics, Inc. -2439.00 USD 57087.085%
IMV Inc. -962.29 Thousand USD 244.437%
Acro Biomedical Co., Ltd. 140.5 Thousand USD -889.263%
Curative Biotechnology, Inc. -97.51 Thousand USD 1525.335%
GB Sciences, Inc. -624.00 USD 222842.788%
Alpha Cognition Inc. -86.02 Thousand USD 1715.654%
HST Global, Inc. - USD -Infinity%
CSL Limited 7.56 Billion USD 99.982%
Halberd Corporation -208.00 USD 668328.365%
Enzolytics Inc. 30.7 Thousand USD -4426.231%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.35 Million USD -2.415%
SYBLEU INC 11.69 Thousand USD -11783.678%
Nuo Therapeutics, Inc. 482.43 Thousand USD -188.105%
argenx SE 1.1 Billion USD 99.875%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. -25.79 Million USD 105.388%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -125.13%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 409.55 Million USD 99.661%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. -8856.00 USD 15794.614%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 44.35 Million USD 96.867%
Provectus Biopharmaceuticals, Inc. -1.14 Million USD 221.754%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 987.98 Thousand USD -40.682%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 9.61 Million USD 85.538%
Cotinga Pharmaceuticals Inc. -83.84 Thousand USD 1757.641%
BioStem Technologies, Inc. 15.42 Million USD 90.989%
ONE Bio Corp. 20.12 Million USD 93.094%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation -11.83 Thousand USD 11844.106%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated -48.25 Thousand USD 2980.116%
Regen BioPharma, Inc. 176.56 Thousand USD -687.22%
Regen BioPharma, Inc. 176.56 Thousand USD -687.22%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. -514.51 Thousand USD 370.143%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd -630.13 Thousand USD 320.573%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. -29 Thousand USD 4892.81%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 450.04 Thousand USD -208.84%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. -319.5 Thousand USD 535.019%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 4.6 Million USD 69.837%
Bioxytran, Inc. -8285.00 USD 16876.282%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. - USD -Infinity%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. -373 Thousand USD 472.631%
Neutra Corp. 14.33 Thousand USD -9595.954%
Windtree Therapeutics, Inc. -82 Thousand USD 1795.018%
PureTech Health plc -1.6 Million USD 186.707%
Coeptis Therapeutics, Inc. -1 Million USD 238.82%
IXICO plc 3.27 Million USD 57.495%
IntelGenx Technologies Corp. -694 Thousand USD 300.276%
Gelesis Holdings, Inc. -1.79 Million USD 177.606%
CSL Limited 7.7 Billion USD 99.982%
Cellectis S.A. 18 Thousand USD -7621.75%